Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Butterfield

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2019
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term ManagementMariana Castells, Joseph Butterfield
Immunology and Allergy Clinics of North America|April 22, 2014
Mast cell sarcoma: clinical managementCatherine R Weiler, Joseph Butterfield
The Journal of Allergy and Clinical Immunology. in Practice|March 7, 2020
The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation SyndromeJoseph Butterfield, Catherine R Weiler
The Journal of Allergy and Clinical Immunology. in Practice|February 13, 2016
Successful rapid desensitization to temozolomide: A case seriesRohit Divekar, Joseph Butterfield, Daniel Maddox
The Journal of Allergy and Clinical Immunology. in Practice|December 3, 2014
Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2αAnupama Ravi, Joseph Butterfield, Catherine R Weiler
Frontiers in Medicine|April 17, 2023
Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndromeFlorence Roufosse, Joseph Butterfield, Jonathan Steinfeld, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 16, 2016
Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin SensitivityRohit Divekar, John Hagan, Matthew Rank, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 2, 2016
Pharmacological treatment options for mast cell activation diseaseGerhard J Molderings, Britta Haenisch, Stefan Brettner, et al.
Leukemia|May 7, 2026
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosisAnne Kaiser, Veronika Lysenko, Renier Myburgh, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 12, 2025
Incidence and Mortality Indicate Sex Differences in Chronic Rhinosinusitis with Nasal PolyposisMichael D'Netto, Alex iAkushev, Phillip Link, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2019
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term ManagementMariana Castells, Joseph Butterfield
Immunology and Allergy Clinics of North America|April 22, 2014
Mast cell sarcoma: clinical managementCatherine R Weiler, Joseph Butterfield
The Journal of Allergy and Clinical Immunology. in Practice|March 7, 2020
The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation SyndromeJoseph Butterfield, Catherine R Weiler
The Journal of Allergy and Clinical Immunology. in Practice|February 13, 2016
Successful rapid desensitization to temozolomide: A case seriesRohit Divekar, Joseph Butterfield, Daniel Maddox
The Journal of Allergy and Clinical Immunology. in Practice|December 3, 2014
Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2αAnupama Ravi, Joseph Butterfield, Catherine R Weiler
Frontiers in Medicine|April 17, 2023
Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndromeFlorence Roufosse, Joseph Butterfield, Jonathan Steinfeld, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 16, 2016
Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin SensitivityRohit Divekar, John Hagan, Matthew Rank, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 2, 2016
Pharmacological treatment options for mast cell activation diseaseGerhard J Molderings, Britta Haenisch, Stefan Brettner, et al.
Leukemia|May 7, 2026
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosisAnne Kaiser, Veronika Lysenko, Renier Myburgh, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 12, 2025
Incidence and Mortality Indicate Sex Differences in Chronic Rhinosinusitis with Nasal PolyposisMichael D'Netto, Alex iAkushev, Phillip Link, et al.
Pageof 2